<p>，/PRNewswire/ -- 股东基金会（Shareholders Foundation, Inc.）宣布，针对某些投资者在 NASDAQ: MCTA 股票上提起的诉讼正在进行中，涉及 Charming Medical Limited 违反证券法的指控。</p>
<p>购买了 Charming Medical Limited (NASDAQ: MCTA) 股票的投资者有一些选择，并且有严格的截止日期。截止日期：2026 年 2 月 17 日。NASDAQ: MCTA 的投资者应联系股东基金会，邮箱为 [email protected] 或拨打 +1(858) 779 - 1554。</p>
<p>2025 年 12 月 22 日，一名 NASDAQ: MCTA 股票的投资者对 Charming Medical Limited 提起了诉讼。原告声称被告作出了虚假和/或误导性的陈述，并/或未能披露 Charming Medical 是一起涉及社交媒体虚假信息和冒充金融专业人士的欺诈性股票推广计划的对象，内部人士和/或关联方利用离岸或代理账户在价格膨胀活动期间协调抛售股票，并且 Charming Medical 的公开声明和风险披露未提及任何关于推动股票价格的虚假谣言和人为交易活动。</p>
<p>那些购买了 Charming Medical Limited (NASDAQ: MCTA) 股票的人应联系股东基金会（Shareholders Foundation, Inc.）。</p>
<p>联系方式：</p>
<p>股东基金会（Shareholders Foundation, Inc.）</p>
<p>Michael Daniels</p>
<p>+1 (858) 779-1554</p>
<p>[email protected]</p>
<p>3111 Camino Del Rio North</p>
<p>Suite 423</p>
<p>圣地亚哥，加州 92108</p>
<p>股东基金会（Shareholders Foundation, Inc.）是一家专业的投资组合法律监测和和解索赔服务机构，进行与股东问题相关的研究，并向投资者通报证券集体诉讼、和解、判决及其他与股票/金融市场相关的法律新闻。股东基金会（Shareholders Foundation, Inc.）并不是一家律师事务所。任何提及的案件、调查和/或和解并未提交/启动/达成，且与股东基金会无关。该信息仅作为公共服务提供，并不构成法律建议，不应依赖。</p>
<p>来源：股东基金会（Shareholders Foundation, Inc.）</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAzJk5ld3NJdGVtSWQ9REM3NzM4MCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDMxMzI1UFJfTkVXU19VU1BSX19fX19EQzc3Mzgw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAzJk5ld3NJdGVtSWQ9REM3NzM4MCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDMxMzI1UFJfTkVXU19VU1BSX19fX19EQzc3Mzgw"/></p>

医疗业 ETF - Vanguard

美国医疗保健供应商 ETF - iShares

标普全球医疗股指数 ETF - iShares

标普医疗保健服务 ETF - SPDR

MCTA

医疗业 ETF - SPDR

<p>一宗针对 Charming Medical Limited（纳斯达克代码：MCTA）的诉讼正在进行中，指控其违反证券法。购买 MCTA 股票的投资者被鼓励在 2026 年 2 月 17 日前联系股东基金，以了解他们的选择。诉讼声称该公司参与了一项欺诈性的股票推广计划，并未披露有关其运营和股票价格操纵的关键信息。欲了解更多信息，投资者可以联系股东基金</p>

<p>, /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ: MCTA shares over alleged securities laws violations by Charming Medical Limited.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- 股东基金会（Shareholders Foundation, Inc.）宣布，针对某些投资者在 NASDAQ: MCTA 股票上提起的诉讼正在进行中，涉及 Charming Medical Limited 违反证券法的指控。</p>
</div><p>Investors who purchased shares of Charming Medical Limited (NASDAQ: MCTA) have certain options and there are short and strict deadlines running. Deadline: February 17, 2026. NASDAQ: MCTA investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.</p>
<div class="lb-trans"><p>购买了 Charming Medical Limited (NASDAQ: MCTA) 股票的投资者有一些选择，并且有严格的截止日期。截止日期：2026 年 2 月 17 日。NASDAQ: MCTA 的投资者应联系股东基金会，邮箱为 [email protected] 或拨打 +1(858) 779 - 1554。</p>
</div><p>On December 22, 2025, an investor in NASDAQ: MCTA shares filed a lawsuit against Charming Medical Limited. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Charming Medical was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professional, that the insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign, and that Charming Medical's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.</p>
<div class="lb-trans"><p>2025 年 12 月 22 日，一名 NASDAQ: MCTA 股票的投资者对 Charming Medical Limited 提起了诉讼。原告声称被告作出了虚假和/或误导性的陈述，并/或未能披露 Charming Medical 是一起涉及社交媒体虚假信息和冒充金融专业人士的欺诈性股票推广计划的对象，内部人士和/或关联方利用离岸或代理账户在价格膨胀活动期间协调抛售股票，并且 Charming Medical 的公开声明和风险披露未提及任何关于推动股票价格的虚假谣言和人为交易活动。</p>
</div><p>Those who purchased shares of Charming Medical Limited (NASDAQ: MCTA) should contact the Shareholders Foundation, Inc.</p>
<div class="lb-trans"><p>那些购买了 Charming Medical Limited (NASDAQ: MCTA) 股票的人应联系股东基金会（Shareholders Foundation, Inc.）。</p>
</div><p>CONTACT:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Shareholders Foundation, Inc.</p>
<div class="lb-trans"><p>股东基金会（Shareholders Foundation, Inc.）</p>
</div><p>Michael Daniels</p>
<div class="lb-trans"><p>Michael Daniels</p>
</div><p>+1 (858) 779-1554</p>
<div class="lb-trans"><p>+1 (858) 779-1554</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>3111 Camino Del Rio North</p>
<div class="lb-trans"><p>3111 Camino Del Rio North</p>
</div><p>Suite 423</p>
<div class="lb-trans"><p>Suite 423</p>
</div><p>San Diego, CA 92108</p>
<div class="lb-trans"><p>圣地亚哥，加州 92108</p>
</div><p>The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.</p>
<div class="lb-trans"><p>股东基金会（Shareholders Foundation, Inc.）是一家专业的投资组合法律监测和和解索赔服务机构，进行与股东问题相关的研究，并向投资者通报证券集体诉讼、和解、判决及其他与股票/金融市场相关的法律新闻。股东基金会（Shareholders Foundation, Inc.）并不是一家律师事务所。任何提及的案件、调查和/或和解并未提交/启动/达成，且与股东基金会无关。该信息仅作为公共服务提供，并不构成法律建议，不应依赖。</p>
</div><p>SOURCE Shareholders Foundation, Inc.</p>
<div class="lb-trans"><p>来源：股东基金会（Shareholders Foundation, Inc.）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAzJk5ld3NJdGVtSWQ9REM3NzM4MCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDMxMzI1UFJfTkVXU19VU1BSX19fX19EQzc3Mzgw" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC77380&amp;Transmission_Id=202602031325PR_NEWS_USPR_____DC77380&amp;DateId=20260203"/></p>

在 Charming Medical Limited（纳斯达克股票代码：MCTA）中亏损的投资者应联系股东基金会，以了解与诉讼相关的事宜